ClinConnect ClinConnect Logo
Search / Trial NCT04653545

Diabetes Diagnosis During Acute Admissions (FIND-IT)

Launched by TAMESIDE GENERAL HOSPITAL · Nov 28, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

**Summary of the FIND-IT Clinical Trial**

The FIND-IT trial is a study designed to find out how many people coming to the hospital for acute care may have undiagnosed type 2 diabetes or pre-diabetes. People with type 2 diabetes have a higher risk of serious problems, such as heart failure and heart attacks. This trial aims to screen patients over the age of 30 who visit the Accident and Emergency department or the Acute Medical Unit at Tameside and Glossop Integrated Care NHS Foundation Trust. Researchers will check blood samples, which are already being taken for other medical reasons, to see if patients have high blood sugar levels that indicate diabetes or pre-diabetes.

To participate in this study, you need to be 30 years or older and not have type 1 diabetes. If you join, the blood test will help identify if you have diabetes or pre-diabetes, which means you can receive the right treatment sooner. By identifying these conditions, the trial aims to improve patient outcomes and reduce the overall burden on the healthcare system. If you or a family member are visiting the hospital and meet the eligibility criteria, you may be approached to take part in this important study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged ≥30 years.
  • Males and female sex
  • Exclusion Criteria:
  • Aged \<30 years.
  • Type 1 diabetes

About Tameside General Hospital

Tameside General Hospital is a leading healthcare institution committed to advancing medical research and improving patient outcomes through clinical trials. With a robust infrastructure and a multidisciplinary team of experienced healthcare professionals, the hospital prioritizes patient safety and ethical standards in all research activities. Tameside General Hospital actively participates in a variety of clinical studies across diverse therapeutic areas, fostering innovation and contributing to the advancement of evidence-based medicine. Through its dedication to high-quality research and collaboration with academic and industry partners, Tameside General Hospital plays a vital role in shaping the future of healthcare.

Locations

Ashton Under Lyne, Greater Manchester, United Kingdom

Patients applied

0 patients applied

Trial Officials

Edward Jude

Principal Investigator

Tameside and Glossop Integrated Care NHS FT

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials